Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Newly diagnosed type 2 diabetes patients based on American Diabetes Association criteria (2011) for diagnosis of diabetes~Exclusion Criteria:~* previous intake of oral hypoglycemic agents for treatment of diabetes or other hyperglycemia associated conditions~* intake of glucocorticoids in the past one year~* major illnesses of heart, lung, kidney, and liver.

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Metformin (Type: ACTIVE_COMPARATOR): patients receiving fixed dose metformin 1000 mg daily
- Pioglitazone (Type: ACTIVE_COMPARATOR): patients receiving fixed dose pioglitazone 30 mg daily

Based on this trial design, predict the completion outcome and termination type (if applicable).